Rothera Mark

Average Profitability
19.88%
Insider Buys Quantity
4
Insider Buys Sum
$436,821.68
Insider Sells Quantity
13
Insider Sells Sum
$5.11M

Insider Activity of Rothera Mark

The largest purchase of all time was on 2013-06-25 and amounted to 25000 shares of PTC Therapeutics, Inc. for $375,000.

The largest sale of all time was on 2015-02-23 and amounted to 23000 shares of PTC Therapeutics, Inc. for $1.5M.

Biography of Rothera Mark

No biography is available at this moment.

2023-12-01PurchaseViracta Therapeutics, Inc.
VIRX
President and CEO
47,906
0.1301%
$0.49$23,627+20.31%
2023-11-30PurchaseViracta Therapeutics, Inc.
VIRX
President and CEO
52,094
0.1374%
$0.49$25,734+15.55%
2016-03-03PurchasePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
2,000
0.006%
$6.23$12,460+31.23%
2015-03-17SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
10,700
0.032%
$76.64$820,048-54.53%
2015-03-13SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
300
0.0009%
$76.36$22,908-50.72%
2015-02-25SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
11,000
0.0332%
$73.49$808,390-48.17%
2015-02-24SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
1,000
0.0029%
$67.70$67,700-46.21%
2015-02-23SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
23,000
0.07%
$65.40$1.5M-40.89%
2015-01-20SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
3,000
0.0091%
$60.02$180,060-19.81%
2015-01-16SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
2,300
0.007%
$58.67$134,941-17.83%
2015-01-14SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
1,200
0.0037%
$58.62$70,344-14.91%
2015-01-13SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
8,500
0.026%
$57.96$492,655-14.38%
2014-09-26SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
3,000
0.0103%
$46.90$140,700+11.78%
2014-09-25SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
10,100
0.0343%
$44.38$448,225+16.46%
2014-09-24SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
2,900
0.0098%
$43.18$125,234+18.54%
2014-09-15SalePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
8,000
0.0271%
$36.24$289,910+41.97%
2013-06-25PurchasePTC Therapeutics, Inc.
PTCT
Chief Commercial Officer
25,000
0.0898%
$15.00$375,000+8.52%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.